Drugmakers, PBMs must face RICO claims over insulin drug pricing - Reuters

2:16pm PDT - July 12th, 2021    sue bird - Reuters

Drug manufacturers Eli Lilly and Co, Novo Nordisk Inc and Sanofi-Aventis US LLC, along with leading pharmacy benefit managers must face drug wholesalers' class action claims that they schemed to inflate the price of insulin drugs, a federal judge has ruled.